-
Pulse check: Exploring the potential of the shock index as a biomarker for cancer-therapy-related cardiotoxicity in breast cancer patients J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-04-09 Anju Nohria MD MSc, Osnat Itzhaki Ben Zadok MD MSc
-
Prognostic value of myocardial flow reserve vs corrected myocardial flow reserve in patients without obstructive coronary artery disease J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-04-07 Daniel M. Huck MD MPH, Brittany N. Weber MD PhD, Jenifer M. Brown MD, Diana Lopez MD, Jon Hainer BS, Ron Blankstein MD, Sharmila Dorbala MD MPH, Sanjay Divakaran MD MPH, Marcelo F. Di Carli MD
Myocardial flow reserve (MFR) by positron emission tomography (PET) is a validated measure of cardiovascular risk. Elevated resting rate pressure product (RPP = heart rate x systolic blood pressure) can cause high resting myocardial blood flow (MBF), resulting in reduced MFR despite normal/near-normal peak stress MBF. When resting MBF is high, it is not known if RPP-corrected MFR (MFR) helps reclassify
-
Sequential 18F-fluorodeoxyglucose positron emission tomography imaging in cardiac sarcoidosis: Editorial Comment for a manuscript entitled: ‘Role of serial 18FDG-PET in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis’ J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-04-05 Brett W. Sperry, Suchith Vuppala
-
Positron emission tomography assessment of coronary microvascular angina in patients with angina and nonobstructive coronary artery disease J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-26 Anahita Tavoosi MD, Amélie Paquin MD, Robert deKemp PhD, Aun-Yeong Chong MD, Kevin Emery Boczar MD, Rob S.B. Beanlands MD, Thais A. Coutinho MD
-
Communication, it is all about improving patients’ care J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-25 Nadeem Shorbaji MD, Samia Massalha MD
-
How to assess nonresponsiveness to vasodilator stress J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-20 Phillip Lim MD, Vikram Agarwal MD MPH, Krishna K. Patel MD MSc
Myocardial perfusion imaging (MPI) is a powerful tool for the functional assessment of ischemia in patients with suspected or known coronary artery disease (CAD). Given that the diagnostic accuracy and prognostic value of MPI and post-test management are highly dependent on achieving an adequate stress vasodilatory response, it is critical to identify those who may not have adequately responded to
-
Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with breast cancer J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-18 Charles-Edouard Decorads MD, Aurélien Lambert MD, Véronique Roch MSc, Laetitia Imbert PhD, Mathieu Perrin MD, Marine Claudin MD, Matthieu Doyen MD, Quentin Citerne PharmD, Zohra Lamiral MSc, Didier Peiffert MD PhD, Catherine Henneton MD, Pierre-Yves Marie MD PhD
-
Translational molecular imaging: Thrombosis imaging with positron emission tomography J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-16 Craig Balmforth, Beth Whittington, Evangelos Tzolos, Rong Bing, Michelle C. Williams, Laura Clark, Carlos Alcaide Corral, Adriana Tavares, Marc Richard Dweck, David Ernest Newby
A key focus of cardiovascular medicine is the detection, treatment, and prevention of disease, with a move towards more personalized and patient-centred treatments. To achieve this goal, novel imaging approaches that allow for early and accurate detection of disease and risk stratification are needed. At present, the diagnosis, monitoring, and prognostication of thrombotic cardiovascular diseases are
-
Role of 18F-sodium fluoride positron emission tomography in imaging atherosclerosis J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-12 Jacek Kwiecinski MD PhD
Atherosclerosis involving vascular beds across the human body remains the leading cause of death worldwide. Coronary and peripheral artery disease, which are almost universally a result of atherosclerotic plaque, can manifest clinically as myocardial infarctions, ischemic stroke, or acute lower-limb ischemia. Beyond imaging myocardial perfusion and blood-flow, nuclear imaging has the potential to depict
-
Role of serial 18F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-11 Joseph Okafor MBChB, Rajdeep Khattar DM FRCP, Vasileios Kouranos MD PhD, Shreya Ohri MBBS, Davide Diana MD, Ehis Ebeke, Alessia Azzu MD, Raheel Ahmed MBBS, Athol Wells MD PhD, A John Baksi MBBS PhD, Rakesh Sharma MBBS PhD, Kshama Wechalekar MBBS DNB
-
Shortening the acquisition times of CZT SPECT imaging for measurement of myocardial blood flow J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-11 Terrence D. Ruddy MD MASNC, R. Glenn Wells PhD
-
18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-11 Jamieson M. Bourque, Ulrika Birgersdotter-Green, Paco E. Bravo, Ricardo P.J. Budde, Wengen Chen, Vivian H. Chu, Vasken Dilsizian, Paola Anna Erba, Cesia Gallegos Kattan, Gilbert Habib, Fabien Hyafil, Yiu Ming Khor, Jaimie Manlucu, Pamela Kay Mason, Edward J. Miller, Marc R. Moon, Matthew W. Parker, Gosta Pettersson, Robert D. Schaller, Riemer H.J.A. Slart, Jordan B. Strom, Bruce L. Wilkoff, Adam Williams
-
How is positron emission tomography/computed tomography imaging revolutionizing cardiac care: Let me count the ways J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-08 Marcelo F. Di Carli MD MASNC
-
Prevalence of balanced ischemia on positron emission tomography relative perfusion imaging among patients with high-risk coronary artery disease J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-03-02 Krishna K. Patel MD MSc, Annapoorna Singh MD, Raed Qarajeh MD, Islam Shatla MD, Femina S. Patel MD, Kyle Lehenbauer MD, Rahul Myadam MD, A. Iain McGhie MD, Timothy M. Bateman MD
-
Potential application of 68Ga-FAPI PET/CT for diagnosing cardiac sarcoidosis J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-24 Ritanshu Solanki MD, Harpreet Singh MD, Vansha Mehta MBBS, Prashant Panda MD DM, Manphool Singhal MD, Ashwani Sood MD, Bhagwant Rai Mittal MD
Detecting cardiac sarcoidosis; a potentially life-threatening condition is challenging and requires a multimodality imaging approach using echocardiography, PET/CT and CMR. Although 18F-FDG is the recommended PET tracer for evaluating cardiac sarcoidosis, it is limited by physiological cardiac FDG uptake and requires stringent patient preparation/ dietary modifications before imaging. We hereby present
-
Expanding the repertoire of 18F-labeled PET MPI radiotracers J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-24 René R. Sevag Packard MD PhD
-
How might coronary sinus reducer treatment change myocardial perfusion? J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-21 Robert M. Bober MD, Nils P. Johnson MD MS
-
Characterisation and management of expected and unexpected urgent findings from positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in cardiovascular disease J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-20 Alexander Liu MBBS MRCP, Liam Cain BMBS BMedSci, Lionel T. Munemo MBChB FCNP(SA), Raheel Ahmed MBBS MRCP, Vasileios Kouranos MD PhD, Rakesh Sharma MRCP PhD, Kshama Wechalekar MBBS DRM DNB
Cardiac F-fluorodeoxyglucose (FDG)-PET-CT plays an important role in the assessment of cardiovascular diseases. Effective management of urgent scan findings facilitates optimal patient care. We characterised the management of urgent, expected and unexpected findings in patients referred for cardiac [F]fluorodeoxyglucose integrated with computed tomography (FDG-PET-CT) at the Royal Brompton Hospital
-
Feasibility of myocardial blood flow quantification to detect flow-limited coronary artery disease with a one-day rest/stress continuous rapid imaging protocol on cardiac-dedicated cadmium zinc telluride single photon emission computed tomography J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-20 Jiao Wang, Yue Chen, Hongxin Chu, Zekun Pang, Bailing Hsu, Jianming Li
It is clinically needed to explore a more efficient imaging protocol for single photon emission computed tomography (SPECT) myocardial blood flow (MBF) quantitation derived from cadmium zinc telluride (CZT) SPECT camera for the routine clinical utilization. One hundred and twenty patients with matched clinical characteristics and angiographic findings who completed one-day rest/stress SPECT imaging
-
President's message: Building a large leadership tent: The need for strong collaboration with nonclinician colleagues J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-16 Lawrence M. Phillips MD FASNC
-
Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-13 Chao Ren MS, Qingqing Pan MD/PhD, Chao Fu MS, Peipei Wang MD/MS, Zhiquan Zheng MS, Bailing Hsu PhD, Li Huo MD/PhD
This study assessed the imaging characteristics, pharmacokinetics and safety of XTR004, a novel F-labeled Positron Emission Tomography (PET) myocardial perfusion imaging tracer, after a single injection at rest in humans. Eleven healthy subjects (eight men and three women) received intravenous XTR004 (239–290 megabecquerel [MBq]). Safety profiles were monitored on the dosing day and three follow-up
-
When should myocardial perfusion imaging be a first-test choice? J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-13 Mahmoud Al Rifai MD MPH, David Winchester MD MS
-
Navigating the positron emission tomography vs. single-photon emission computed tomography debate: A closer look at evidence and guidelines J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-02 M, a, r, c, e, l, o, , F, ., , D, i, , C, a, r, l, i, , M, D, , M, A, S, N, C
-
Deep learning approach for automated segmentation of myocardium using bone scintigraphy single-photon emission computed tomography/computed tomography in patients with suspected cardiac amyloidosis J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-02-01 Abhijit Bhattaru, Chaitanya Rojulpote, Mahesh Vidula, Jeffrey Duda, Matthew T. Maclean, Sophia Swago, Elizabeth Thompson, James Gee, Janice Pieretti, Brian Drachman, Adam Cohen, Sharmila Dorbala, Paco E. Bravo, Walter R. Witschey
We employed deep learning to automatically detect myocardial bone-seeking uptake as a marker of transthyretin cardiac amyloid cardiomyopathy (ATTR-CM) in patients undergoing 99mTc-pyrophosphate (PYP) or hydroxydiphosphonate (HDP) single-photon emission computed tomography (SPECT)/computed tomography (CT). We identified a primary cohort of 77 subjects at Brigham and Women’s Hospital and a validation
-
Ejection fraction and ventricular volumes on rubidium positron emission tomography: Validation against cardiovascular magnetic resonance J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-28 Yushui Han MS, Ahmed Ibrahim Ahmed MD MPH, Jean Michel Saad MD, Fares Alahdab MD MSc, Mahmoud S. Al Rifai MD, Venkatesh L. Murthy, Mouaz H. Al-Mallah MD MSc
Cardiovascular magnetic resonance (CMR) is the non-invasive gold standard for non-invasively determining left ventricular volumes (LVVs) and ejection fraction (EF). We aimed to assess the accuracy of LVV and left ventricular ejection fraction measured by positron emission tomography (PET) as compared to CMR. Patients who underwent both PET and CMR within 1 year were identified from prospective institutional
-
Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritis J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-22 Hadil Zureigat MD, Giovanni Civieri MD, Shady Abohashem MD, Michael T. Osborne MD, Daniel H. Solomon MD, Jon T. Giles MD MPH, Joan Bathon MD, Elena Massarotti MD, Sebastian Unizony MD, Ahmed Tawakol MD
: F-FDG-PET-MRF-fluorodeoxyglucose-positron emission tomography-magnetic resonance; L: left; R: right; RA: rheumatoid arthritis; SUV: standardized uptake value; TBR: target-to-background ratio. [Display omitted]
-
Feasibility of PiB positron emission tomography/computed tomography for treatment monitoring with Tafamidis in a patient with transthyretin cardiac amyloidosis J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-20 Kiriko Fujioka, Takashi Norikane, Yasukage Takami, Yuka Yamamoto, Takahisa Noma, Yoshihiro Nishiyama
We present a 77-year-old woman with wild-type ATTR cardiac amyloidosis (ATTR-CA) who presented with dyspnea, arrhythmia, and elevated NT-pro BNP. Initial imaging including cardiac MRI, PYP scintigraphy, PiB PET/CT and NaF PET/CT revealed cardiac abnormalities. Tafamidis treatment was initiated. After 14 months, symptomatic improvement and reduced NT-pro BNP were observed. Cardiac MRI and PYP scintigraphy
-
Noninvasive diagnosis of a massive cardiac lipoma with multimodality imaging J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-20 Yoshito Kadoya MD PhD, Gary R. Small MBChB PhD, Terrence D. Ruddy MD MASNC
-
Identification of lipomatous metaplasia on computed tomography images helps confirm prior silent myocardial infarction associated with equivocal perfusion abnormality on single-photon emission computed tomography/computed tomography imaging J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-20 Matthieu Dietz MD PhD, Thomas Bochaton MD PhD, Laure Al Mansour MD, Jeremie Tordo MD, Anthime Flaus MD PhD
-
A good assist is followed by a goal J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Emilia Zampella MD PhD, Roberta Assante MD PhD, Wanda Acampa MD PhD
-
Comparative predictors of mortality among patients referred for stress single-photon emission computed tomography versus positron emission tomography myocardial perfusion imaging J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Alan Rozanski, Robert J.H. Miller, Donghee Han, Heidi Gransar, Sean W. Hayes, John D. Friedman, Louise E.J. Thomson, Daniel S. Berman
There is currently little information regarding the usage and comparative predictors of mortality among patients referred for single-photon emission computed tomography (SPECT) versus positron emission tomography (PET) myocardial perfusion imaging (MPI) within multimodality imaging laboratories. We compared the clinical characteristics and mortality outcomes among 15,718 patients referred for SPECT-MPI
-
Machine learning models for positron emission tomography myocardial perfusion imaging J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 M, i, c, h, e, l, l, e, , C, ., , W, i, l, l, i, a, m, s, , M, B, C, h, B, , P, h, D
-
Invasive vs non-invasive testing J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 A, m, i, , E, ., , I, s, k, a, n, d, r, i, a, n, , M, D, , M, A, C, C, , M, A, S, N, C
-
Response to letter to the editor J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Juan Carlo Avalon DO, Raymond Raylman PhD, Yasmin S. Hamirani MD
-
Targeting atherosclerosis with antihypertensive therapy J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Terrence D. Ruddy MD MASNC, Yoshito Kadoya MD PhD, Gary R. Small PhD MB ChB
-
JNC Awards J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 A, m, i, , E, ., , I, s, k, a, n, d, r, i, a, n
-
Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear Cardiology J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Panithaya Chareonthaitawee MD, Timothy M. Bateman MD, Rob S. Beanlands MD, Daniel S. Berman MD, Dennis A. Calnon MD, Marcelo F. Di Carli MD, Gary V. Heller MD, Venkatesh L. Murthy MD PhD, Krishna K. Patel MD MSc, Thomas H. Schindler MD, Viviany R. Taqueti MD MPH, Christiane C. Wiefels MD, Mouaz H. Al-Mallah MD
-
Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Olivia Hudson MD, Fadi G. Hage MD FAHA FACC MASNC
-
Publishing in a Medical Journal: insights from successive Editors-in-chief of JNC J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 A, h, m, e, d, , T, a, w, a, k, o, l, , M, D
-
In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Daniel O. Johnsrud MD, Steven C. Port MD
-
Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Bruno B. Lima MD PhD, Dominik C. Benz MD
-
Targeted imaging: the key for direct visualization of myocardial inflammation in patients? J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 T, h, e, r, e, s, a, , R, e, i, t, e, r, , M, D
-
Coronary artery calcium score as a gatekeeper: are we there yet? J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Bonnia Liu, Nathan Better
-
Time-efficient cardiac imaging: early post-injection stress-first protocol myocardial perfusion SPECT with a CZT camera J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Luca Camoni MSc, Francesco Dondi MD
-
Infective endocarditis related abscess is an important complication and requires awareness on all imaging modalities J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Maurits S.H. Blomjous MD, Ricardo P.J. Budde MD PhD
-
Financial hardship and major adverse cardiovascular events: The role of advanced cardiac imaging J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Kaitlin Shinn MD, Venkatesh L. Murthy MD PhD
-
Extra-cardiac uptake on technetium-99m pyrophosphate (Tc-99m PYP) scan: not just a matter of the heart J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Yiu Ming Khor MBBS MMed MRCP, Sharmila Dorbala MD MPH FASNC
-
In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 T, i, m, o, t, h, y, , M, ., , B, a, t, e, m, a, n, , M, D, , M, A, S, N, C
-
Correction to: The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Mandy Kamerman, Joris D. van Dijk, Jorik R. Timmer, Jan Paul Ottervanger, Siert Knollema, Pieter L. Jager, Mohamed Mouden
-
Confessions, the JNC family, and final farewell J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 A, m, i, , E, ., , I, s, k, a, n, d, r, i, a, n, , M, D, , M, A, C, C, , M, A, S, N, C
-
Increasing frequency of dyspnea among patients referred for cardiac stress testing J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Alan Rozanski MD, Heidi Gransar MS, Sakul Sakul MD, Robert J.H. Miller MD, Donghee Han MD, Sean W. Hayes MD, John D. Friedman MD, Louise E.J. Thomson MBChB, Daniel S. Berman MD
-
ASNC without borders: A global effort in nuclear cardiology J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 M, o, u, a, z, , H, ., , A, l, -, M, a, l, l, a, h, , M, D, , M, S, , M, A, S, N, C
-
What is this image? 2023 Image 3 results: Cardiac tuberculosis presenting as cardiac mass: role of 18F-FDG PET/CT in monitoring response to treatment J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Sarvesh Loharkar, Sunita N. Sonavane, Hetan Shah, Sandip Basu
-
82Rb and [15O]H2O myocardial perfusion PET imaging: a prospective head to head comparison J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Martin Krakauer MD PhD, Afefah Ismail MD, Ulrik Talleruphuus MD, Alexander Cuculiza Henriksen MD, Markus N. Lonsdale MSc PhD, Inge Lise Rasmussen MSc PhD, Stefan Fuglsang MSc, Eva Prescott MD DMSc, Peter Hovind MD DMSc, Lisbeth Marner MD PhD DMSc
-
Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Arghavan Jahandideh MSc, Jenni Virta MSc, Xiang-Guo Li PhD, Heidi Liljenbäck MSc, Olli Moisio PhD, Jesse Ponkamo MSc, Noora Rajala PhD, Marion Alix MSc, Jukka Lehtonen MD PhD, Mikko I. Mäyränpää MD PhD, Tiina A. Salminen PhD, Juhani Knuuti MD PhD, Sirpa Jalkanen MD PhD, Antti Saraste MD PhD, Anne Roivainen PhD
-
Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Kenichi Nakajima MD PhD, Takayuki Shibutani PhD, Francesc Massanes PhD, Takeshi Shimizu PhD, Shohei Yoshida MD PhD, Masahisa Onoguchi PhD, Seigo Kinuya MD PhD, A. Hans Vija PhD
-
Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Mehul Adhaduk MD MS, Bishow Paudel MD, Kan Liu MD PhD, Mahi Ashwath MD MBA, Milena A. Gebska MD PhD MME, Kimberly Delcour DO, Riley J. Samuelson MA, Michael Giudici MD
-
Hybridizing machine learning in survival analysis of cardiac PET/CT imaging J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Luis Eduardo Juarez-Orozco MD PhD, Mikael Niemi MD, Ming Wai Yeung MSc, Jan Walter Benjamins BSc, Teemu Maaniitty MD PhD, Jarmo Teuho PhD, Antti Saraste MD PhD, Juhani Knuuti MD, Pim van der Harst MD, Riku Klén PhD
-
Detection and correction of patient motion in dynamic 15O-water PET MPI J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Nana L. Christensen BLS, Jonny Nordström PhD, Simon Madsen MD, Michael A. Madsen MD PhD, Lars C. Gormsen MD PhD, Tanja Kero MD PhD, Mark Lubberink PhD, Lars P. Tolbod PhD
-
Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study J. Nucl. Cardiol. (IF 2.4) Pub Date : 2024-01-18 Lina Li MD, Jie Gao MD, Bi-Xi Chen MD, Xingpeng Liu MD, Liang Shi MD, Yanjiang Wang MD, Li Wang MD, Yidan Wang MD, Pixiong Su MD, Min-Fu Yang MD, Boqia Xie MD